HighMark Wealth Management’s Reata Pharmaceuticals, Inc. Class A Common Stock RETA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q3
Sell
-21,219
Closed -$2.16M 584
2023
Q2
$2.16M Sell
21,219
-50
-0.2% -$5.1K 1.63% 8
2023
Q1
$1.93M Buy
21,269
+11,588
+120% +$1.05M 1.51% 8
2022
Q4
$368K Buy
+9,681
New +$368K 0.28% 33